Citigroup
ARRY

Citigroup’s Array Biopharma Inc ARRY Stock Holding History

Citigroup’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-87,400
Closed -$4.05M – 7954
2019
Q2 		$4.05M Buy
87,400
+16,500
+23% +$463K ﹤0.01% 2155
2019
Q1 		$1.73M Buy
70,900
+29,600
+72% +$616K ﹤0.01% 2812
2018
Q4 		$589K Buy
41,300
+15,800
+62% +$240K ﹤0.01% 3954
2018
Q3 		$388K Sell
25,500
-12,400
-33% -$190K ﹤0.01% 4582
2018
Q2 		$636K Buy
37,900
+22,200
+141% +$353K ﹤0.01% 3837
2018
Q1 		$256K Sell
15,700
-49,100
-76% -$787K ﹤0.01% 4696
2017
Q4 		$829K Sell
64,800
-72,000
-53% -$819K ﹤0.01% 3538
2017
Q3 		$1.68M Buy
136,800
+110,600
+422% +$1.03M ﹤0.01% 2848
2017
Q2 		$219K Buy
26,200
+5,000
+24% +$40.9K ﹤0.01% 4712
2017
Q1 		$190K Buy
21,200
+7,500
+55% +$79.8K ﹤0.01% 4701
2016
Q4 		$120K Sell
13,700
-9,600
-41% -$70.6K ﹤0.01% 5663
2016
Q3 		$157K Buy
+23,300
New +$90.1K ﹤0.01% 4863

Other funds holding ARRY

ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Citigroup's ARRY Position: Q3 2019 in Review

Citigroup sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 1,539,322 shares — an estimated $71.3M sold.

Citigroup first reported a position in ARRY in Q2 2013 and held it in 25 quarters. The position peaked at $71.3M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

  • Citigroup reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
  • Citigroup sold 1,539,322 Array Biopharma Inc shares in Q3 2019, an estimated $71.3M.
  • Citigroup first reported a position in Array Biopharma Inc in Q2 2013 and held it in 25 quarters.
  • Citigroup's Array Biopharma Inc position peaked at $71.3M in Q2 2019.
  • 1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Citigroup's 13F filing for Q3 2019, filed 8 Nov 2019.